Search
left ventricular ejection fraction (LVEF)
A measure of pumping action of the left ventricle (LV) of the heart.
Indications:
- assessment of heart failure
- coronary artery disease
- monitoring of cardiotoxicity during chemotherapy [1]
Reference interval:
- normal 65 +/- 8 %, 56-78%.
Clinical significance:
- lower values indicate ventricular dysfunction
Principle:
- LVEF is the difference between LV end diastolic volume & LV end systolic volume (stroke volume) divided by LV end diastolic volume (i.e. the % of blood emptied from the left ventricle through the aortic valve during systole)
stroke volume / LV end diastolic volume
Notes:
- serial LVEF measurements best with 3D echocardiography
- variability in different measurements ~6% [3]
- lowest mortality with LVEF of 60-65% [4]
General
ejection fraction (EF)
References
- Thavendiranathan P et al.
Reproducibility of echocardiographic techniques for sequential
assessment of left ventricular ejection fraction and volumes:
Application to patients undergoing cancer chemotherapy.
J Am Coll Cardiol 2013 Jan 8; 61:77
PMID: 23199515
- Mor-Avi V and Lang RM.
Is echocardiography reliable for monitoring the adverse
cardiac effects of chemotherapy?
J Am Coll Cardiol 2013 Jan 8; 61:85
PMID: 23199517
- Konstam MA, Abboud FM
Ejection Fraction: Misunderstood and Overrated (Changing the
Paradigm in Categorizing Heart Failure).
Circulation. 2017;135(8):717-719
PMID: 28223323
- Pellikka PA, She L, Holly TA et al.
Variability in ejection fraction measured by echocardiography,
gated single-photon emission computed tomography, and cardiac
magnetic resonance in patients with coronary artery disease
and left ventricular dysfunction.
JAMA Netw Open 2018 Aug 31; 1:e181456
Not indexed in PubMed
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2698631
- Wehner GJ, Jing L, Haggerty CM et al.
Routinely reported ejection fraction and mortality in clinical
practice: Where does the nadir of risk lie?
Eur Heart J 2019 Aug 6;
PMID: 31386109
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz550/5544337